NEU vs PYC

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

NEU

NEUREN FPO NZ [NEU]

47LOW

PYC

PYC THERAP FPO [PYC]

53MEDIUM

Score Breakdown

NEU PYC
Technical
61
60
Catalyst
50
55
Sentiment
50
50
Fundamental
62
42
Momentum
26
75
Risk Gate
43
50

Key Metrics

NEU Metric PYC
$2.1BMarket Cap$1.5B
725KAvg Volume (20d)1.1M
+4.9%Short Interest+0.3%
$22.98552-Week High$1.755
$11.00052-Week Low$0.848
+0.2%Daily Change-1.3%
$16.530Reference Price$1.530
+8.7%ROE-47.5%
+47.1%Profit Margin-231.3%

Active Signals

NEU Signals

Beating the Small Ords index — relative strength of 1.37, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Cash positive / operating cashflow positive
Revenue in sharp decline (-81%)
Piotroski F-Score strong (7/9, low-confidence approx)
EPS estimates revised upward (+10pts)
Post-earnings drift: negative surprise (SUE -10)
Earnings in sharp decline (-88% QoQ)

PYC Signals

MACD momentum is losing steam
Bollinger Bands are tightening — volatility is coiling up for a potential breakout
Beating the Small Ords index — relative strength of 1.23, so it's outpacing the pack
Trading above the 200-day average — the long-term trend is on your side
Adequate cash runway (7 quarters)
Very high P/S ratio (74.1x)
Revenue in sharp decline (-25%)
Piotroski F-Score weak (3/9, low-confidence approx)

Ask Scout AI to compare NEU and PYC in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

NEU vs TRI →NOX vs PAR →NOX vs SPL →NSB vs NTI →NSB vs NXN →
NEU Full Analysis → PYC Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).